Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance

Sensors (Switzerland)

Volumn 12, Issue 5, 2012, Pages 5596-5607

  Real Fernández, Feliciana ^a   Passalacqua, Irene ^a   Peroni, Elisa ^b   Chelli, Mario ^a   Lolli, Francesco ^a,c   Papini, Anna Maria ^a,b   Rovero, Paolo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Université Paris Seine   (France)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Biacore; Glycopeptide CSF114(Glc); Immunoassay; Multiple sclerosis; Serodiagnosis; Surface plasmon resonance

Indexed keywords

AUTOANTIBODY; GLYCOPEPTIDE;

ARTICLE; BLOOD; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC PROCEDURES; HUMAN; IMMUNOLOGY; METHODOLOGY; MULTIPLE SCLEROSIS; SURFACE PLASMON RESONANCE;

AUTOANTIBODIES; BIOSENSING TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPEPTIDES; HUMANS; MULTIPLE SCLEROSIS; SURFACE PLASMON RESONANCE;

EID: 84861544418     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s120505596     Document Type: Article

References (40)

1. Ziemssen, T.; Ziemssen, F. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Autoimmun. Rev. 2005, 4, 460-467.
2. Lassmann, H. Neuropathology in multiple sclerosis: New concepts. Mult. Scler. 1998, 4, 93-98.
3. Lucchinetti, C.; Bruck, W.; Rodriguez, M.; Lassmann, H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol. 1996, 6, 259-274.
4. Martin, R.; McFarland, H. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 1995, 32, 121-182.
5. Miller, D.; Barkhof, F.; Montalban, X.; Thompson, A.; Filippi, M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: Natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol. 2005, 4, 281-288.
6. Rovira, A.; Swanton, J.; Tintoré, M.; Huerga, E.; Barkhof, F.; Filippi, M.; Frederiksen, J.L.; Langkilde, A.; Miszkiel, K.; Polman, C.; et al. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch. Neurol. 2009, 66, 587-592.
7. Freedman, M.S.; Thompson, E.J.; Deisenhammer, F.; Giovannoni, G.; Grimsley, G.; Keir, G.; Ohman, S.; Racke, M.K.; Sharief, M.; Sindic, C.J.; et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: A consensus statement. Arch. Neurol. 2005, 62, 865-870.
8. Luque, F.A.; Jaffe, S.L. Cerebrospinal fluid analysis in multiple sclerosis. Int. Rev. Neurobiol. 2007, 79, 341-356.
9. Doyle, H.A.; Mamula, M.J. Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol. 2001, 22, 443-449.
10. Alcaro, M.C.; Lolli, F.; Migliorini, P.; Chelli, M.; Rovero, P.; Papini, A.M. Peptides as autoimmune diseases antigenic probes. Chim Oggi. 2007, 25, 14-16.
11. Leslie, D.; Lipsky, P.; Notkins, A.L. Autoantibodies as predictors of disease. J. Clin. Invest. 2001, 108, 1417-1422.
12. Baker, M. In biomarkers we trust? Nat. Biotechnol. 2005, 23, 297-304.
13. Roland, P.; Atkinson, J.A.; Lesko, L.J. Use of biomarkers from drug discovery through clinical practice: Report of the ninth european federation of pharmaceutical sciences conference on optimizing drug development. Clin. Pharm. Ther. 2003, 73, 284-291.
14. Mazzucco, S.; Matà, S.; Vergelli, M.; Fioresi, R.; Nardi, E.; Mazzanti, B.; Chelli, M.; Lolli, F.; Ginanneschi, M.; Pinto, F.; et al. A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases. Bioorg. Med. Chem. Lett. 1999, 9, 167-172.
15. Carotenuto, A.; D'Ursi, A.M.; Nardi, E.; Papini, A.M.; Rovero, P. Conformational analysis of a glycosylated human myelin oligodendrocyte glycoprotein peptide epitope able to detect antibody response in multiple sclerosis. J. Med. Chem. 2001, 44, 2378-2381.
16. Lolli, F.; Mazzanti, B.; Pazzagli, M.; Peroni, E.; Alcaro, M.C.; Sabatino, G.; Lanzillo, R.; Brescia Morra, V.; Santoro, L.; Gasperini, C.; et al. The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis. J. Neuroimmunol. 2005, 167, 131-137.
17. Papini, A.M.; Chelli, M.; Rovero, P.; Lolli, F. Glycopeptides, Their Preparation and Use in the Diagnosis or Therapeutic Treatment of Multiple Sclerosis. International Patent Application Number WO 03/000733 A2, 2003.
18. Carotenuto, A.; D'Ursi, A.M.; Mulinacci, B.; Paolini, I.; Lolli, F.; Papini, A.M.; Novellino, E.; Rovero, P. Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis. J. Med. Chem. 2006, 49, 5072-5079.
19. Carotenuto, A.; Alcaro, M.C.; Saviello, M.R.; Peroni, E.; Nuti, F.; Papini, A.M.; Novellino, E.; Rovero, P. Designed glycopeptides with different β-turn types as synthetic probes for the detection of autoantibodies as biomarkers of multiple sclerosis. J. Med. Chem. 2008, 51, 5304-5309.
20. Nuti, F.; Paolini, I.; Cardona, F.; Chelli, M.; Lolli, F.; Brandi, A.; Goti, A.; Rovero, P.; Papini, A.M. FMOC-protected iminosugar modified asparagine derivatives as building blocks for glycomimetics-containing peptides. Bioorg. Med. Chem. 2007, 15, 3965-3973.
21. Nuti, F.; Peroni, E.; Real-Fernández, F.; Bonache, M.A.; Le Chavalier-Isaad, A.; Chelli, M.; Lubin-Germain, N.; Uziel, J.; Rovero, P.; Lolli, F.; et al. Post-translationally modified peptides efficiently mimicking neo-antigens: A challenge for theragnostics of autoimmune diseases. Biopolymers (Pept. Sci.) 2010, 94, 791-799.
22. Baker, K.N.; Rendall, M.H.; Patel, A.; Boyd, P.; Hoare, M.; Freedman, R.B.; James, D.C. Rapid monitoring of recombinant protein products: A comparison of current technologies. Trends Biotechnol. 2002, 20, 149-156.
23. Thorpe, R.; Swanson, S.J. Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PRCA): An assessment of available procedures. Nephrol Dial Transpl. 2005, 20, iv16-iv22.
24. Gomes, P.; Giralt, E.; Andreu, D. Surface plasmon resonance screening of synthetic peptides mimicking the immunodominant region of C-S8c1 foot-and-mouth disease virus. Vaccine 2000, 18, 362-370.
25. Gomes, P.; Giralt, E.; Andreu, D. Direct single-step surface plasmon resonance analysis of interactions between small peptides and immobilized monoclonal antibodies. J. Immunol. Methods 2000, 235, 101-111.
26. Hearty, S.; Conroy, P.J.; Ayyar, B.V.; Byrne, B.; O'Kennedy, R. Surface plasmon resonance for vaccine design and efficacy studies: Recent applications and future trends. Expert Rev. Vaccines 2010, 9, 645-664.
27. Gomara, M.J.; Ercilla, G.; Alsina, M.A.; Haro, I. Assessment of synthetic peptides for hepatitis a diagnosis using biosensor technology. J. Immunol. Methods 2000, 246, 13-24.
28. Mayer, K.M.; Hao, F.; Lee, S.; Nordlander, P.; Hafner, J.H. A single molecule immunoassay by localized surface plasmon resonance. Nanotechnology 2010, doi: 10.1088/0957-4484/21/25/255503.
29. Malmqvist, M. BIACORE: An affinity biosensor system for characterization of biomolecular interactions. Biochem. Soc. Trans. 1999, 27, 335-340.
30. Ayela, C.; Roquet, F.; Valera, L; Granier, C.; Nicu, L.; Pugnière, M. Antibody-antigenic peptide interactions monitored by SPR and QCM-D: A model for SPR detection of IA-2 autoantibodies in human serum. Biosens. Bioelectron. 2007, 22, 3113-3119.
31. Stigter, E.C.A.; de Jong, G.J.; van Bennekom, W.P. An improved coating for the isolation and quantitation of interferon-γ in spiked plasma using surface plasmon resonance (SPR). Biosens. Bioelectron. 2005, 21, 474-482.
32. Vaisocherová, H.; Mrkvová, K.; Piliarik, M.; Jinoch, P.; Šteinbachová, M.; Homola, J. Surface plasmon resonance biosensor for direct detection of antibody against Epstein-Barr virus. Biosens. Bioelectron. 2007, 22, 1020-1026.
33. Ritter, G.; Cohen, L.S.; Williams, C.; Richards, E.C.; Old, L.J.; Welt, S. Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33. Cancer Res. 2001, 61, 6851-6859.
34. Cherif, B.; Roget, A.; Villiers, C.L.; Calemczuk, R.; Leroy, V.; Marche, P.N.; Livache, T.; Villiers, M.B. Clinically related protein-peptide interactions monitored in real time on novel peptide chips by surface plasmon resonance imaging. Clin. Chem. 2006, 52, 255-262.
35. Nagel, T.; Ehrentreich-Förster, E.; Singh, M.; Schmitt, K.; Brandenburg, A.; Berka, A.; Bier, F.F. Direct detection of tuberculosis infection in blood serum using three optical label-free approaches. Sens. Actuators B: Chem. 2008, 129, 934-940.
36. Alaedini, A.; Latov, N. A surface plasmon resonance biosensor assay for measurement of anti-GM1 antibodies in neuropathy. Neurology 2001, 56, 855-860.
37. Rizzolo, F.; Sabatino, G.; Chelli, M.; Rovero, P.; Papini, A.M. A convenient microwave-enhanced solid-phase synthesis of difficult peptide sequences: Case study of gramicidin A and CSF114(Glc). Int. J. Pept. Res. Ther. 2007, 13, 203-208.
38. Habbema, J.D.; Eijkemans, R.; Krijnen, J.; Knottnerus, J.E. Analysis of data on the accuracy of diagnostic tests. In The Evidence Base of Clinical Diagnosis; Knottnerus, J.E., Ed.; BMJ Books: London, UK, 2002; pp. 117-143.
39. Lucchinetti, C.; Brück, W.; Parisi, J.; Scheithauer, B.; Rodriguez, M.; Lassmann, H. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann. Neurol. 2000, 47, 707-717.
40. Lolli, F.; Mulinacci, B.; Carotenuto, A.; Bonetti, B.; Sabatino, G.; Mazzanti, B.; D'Ursi, A.M.; Novellino, E.; Pazzagli, M.; Lovato, L.; et al. An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis. Proc. Natl. Acad. Sci. USA 2005, 102, 10273-10278.